Delivery Order SPE2DB24D2101-SPE2DB25FKPXW
- Not listed
- The Defense Logistics Agency awarded a $39,518.60 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication, with a completion date of September 15, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $39,518.60 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml pharmaceutical product, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $31,614.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication. The contract, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive award. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $47,422.32 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injectables. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 10, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's pharmaceutical supply services to support federal medical...
- The Defense Logistics Agency Medical Supply Chain awarded a $15,807.44 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Somatuline Depot 120 mg/0.5 mL injectable medication. The contract utilizes firm fixed-price pricing with a completion date of October 15, 2025, and carries no set-aside designation, indicating competitive award to this qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,951.86 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injections. The award, issued on September 9, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. The contract is non-set-aside and competitively awarded, with performance of work taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Somatuline Depot 90 mg/0.3 ml injectable medication. This firm fixed-price delivery order, valued at $11,233.02, represents a non-competitive child award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion blanket agreement running through December 2026. The product will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Somatuline Depot 120 mg/0.5 mL pharmaceutical product. This firm fixed-price delivery order, valued at $3,951.86, represents a non-set-aside competitive award with an ultimate completion date of August 28, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,616.51 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Somatuline Depot 90 mg/0.3 ml injectable medication. This is a firm fixed price delivery order with no set-aside designation, utilizing open competition. The order is scheduled for ultimate completion by October 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Somatuline Depot is a somatostatin...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 23, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml injection medication, valued at $3,951.86. This is a firm fixed-price delivery order with an ultimate completion date of October 15, 2025, to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract was funded by the Defense Medical Supply Chain and carries no set-aside designation, indicating it was competitively awarded....
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPXWDelivery Order
The Defense Logistics Agency awarded a $19,759.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication. This competitive award, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside provisions were applied to this award, indicating it was competitively procured. This delivery order supports the Defense Health Agency's pharmaceutical supply chain requirements through AmerisourceBergen's comprehensive IDC valued at $999,999,999.00 and running through December 2026. The contract vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. Somatuline Depot, a specialty pharmaceutical used for treating neuroendocrine tumors and acromegaly, exemplifies the type of specialized medications AmerisourceBergen delivers under its federal contract portfolio, which encompasses diabetes medications, neurological treatments, pain management pharmaceuticals, and other critical healthcare commodities supporting Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.8k | 9/24/25 |